Referenzen
Produkte Transfektion
Kostenlose Testsamples
Anwendungshinweise:
Im „Transfection Reagent Selection Guide“ können Sie durch Filterfunktionen z.B. für Ihre Kombination aus zu transfizierender Zelle und Nukleinsäure die Liste vorhandener Referenzen durchsuchen. Ebenso können Sie im Feld „Referenzen durchsuchen“ am Anfang der Seite mit passenden Schlagwörtern zu einem Ergebnis gelangen. Eine Referenz zeigt an, dass das gefundene Transfektionsreagenz bereits erfolgreich für die entsprechende Anwendung verwendet wurde. Im Idealfall sind getestete Transfektionsparameter und Transfektionseffizienzen angegeben.
Keine Referenz? > Allgemeine Auswahlhilfe
Wenn Sie keine Referenz gefunden haben, heißt das nicht, dass kein passendes Reagenz zur Verfügung steht, sondern lediglich, dass bisher keine Erfahrungsberichte vorliegen. In diesem Falle kann durch eine Vorauswahl ein erfolgsversprechendes Transfektionsreagenz ausgewählt (Allgemeine Auswahlhilfe) und letztendlich ausgetestet (Kostenlose Testsamples) werden. Wenn Sie einen Erfahrungsbericht für uns schreiben möchten machen wir Ihnen ein Angebot für eine Gegenleistung.
CELL TYPE | DESCRIPTION OF CELL TYPE | CAT.NO. | SPECIES | ORIGIN OF CELLS | COMMON CELL TYPE | GROWTH PROPERTIES | NUCLEIC ACID / DELIVERED MOLECULE | APPLICATION | PRODUCT | REFERENCE TYPE | BIBLIOGRAPHIC DATA | LINK | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
MCF-7 |
Human breast adenocarcinoma cell line | ATCC HTB-22 | Human | breast | cell line | adherent | siRNA | RNA-Interference | K2 Transfection System | application note | ![]() |
||
MCF-7 |
Human breast adenocarcinoma cell line | ATCC HTB-22 | Human | breast | cell line | adherent | siRNA | RNA-Interference | Metafectene PRO | publication | X. Wu et al., PNAS, Nov 2016, 113: E6965 - E6973 | ||
MDA-MB-231 |
Human breast adenocarcinoma cell line | ATCC HTB-26 | Human | breast | cell line | adherent | siRNA | cotransfection (plasmid/siRNA) | Metafectene PRO | publication | S. Liu et al., J. Biol. Chem., 2015, 290(29): 17894-17908; DOI 10.1074/jbc.M114.607184 | Link | |
MDA-MB-231 |
Human breast adenocarcinoma cell line | ATCC HTB-26 | Human | breast | cell line | adherent | siRNA | RNA-Interference | Metafectene | publication | M. Endres et al., Oncotarget, 2016, 7(39): 64244-64259 | Link | |
MDA-MB-231 |
Human breast adenocarcinoma cell line | ATCC HTB-26 | Human | breast | cell line | adherent | siRNA | RNA-Interference | Metafectene | publication | D. Konina et al., Int. J. Mol. Sci., 2021, 22, 8477, doi.org/10.3390/ijms22168477 | Link | |
MDA-MB-231 |
Human breast adenocarcinoma cell line | ATCC HTB-26 | Human | breast | cell line | adherent | siRNA | RNA-Interference | Metafectene PRO | publication | B. von Neubeck et al., Int. J. of Cancer, 2018, 143: 2065–2075, DOI: 10.1002/ijc.31607 | ||
MDA-MB-231 |
Human breast adenocarcinoma cell line | ATCC HTB-26 | Human | breast | cell line | adherent | siRNA | RNA-Interference | Metafectene | publication | M. M. Endres, Dissertation, 2016, Julius-Maximilians-Universität Würzburg | ||
MDA-MB-231 |
Human breast adenocarcinoma cell line | ATCC HTB-26 | Human | breast | cell line | adherent | siRNA | RNA-Interference | Metafectene | publication | A. Hermawan et al., Dissertation, 2015, Ludwig-Maximilians-Universität München | Link | |
MDA-MB-231 |
Human breast adenocarcinoma cell line | ATCC HTB-26 | Human | breast | cell line | adherent | siRNA | RNA-Interference | Metafectene PRO | publication | S. Liu et al., J. Biol. Chem., 2015, 290(29): 17894-17908; DOI 10.1074/jbc.M114.607184 | Link | |
MDA-MB-231 |
Human breast adenocarcinoma cell line | ATCC HTB-26 | Human | breast | cell line | adherent | siRNA | RNA-Interference | Metafectene SI | publication | J.-E. Lee et al., Journal of Proteomics, 2016, 131: 17-28; doi.org/10.1016/j.jprot.2015.10.005 | ||
MDA-MB-231 |
Human breast adenocarcinoma cell line | ATCC HTB-26 | Human | breast | cell line | adherent | siRNA | RNA-Interference | Metafectene | publication | K. Wang et al., J. Biochem. Mol. Toxicol., 2018, e22039, doi.org/10.1002/jbt.22039 | ||
MDA-MB-435S |
Human breast cancer cell line | ATCC HTB-129 | Human | breast | cell line | adherent | siRNA | RNA-Interference | Metafectene PRO | publication | K. Kemppainen et al., Cellular Signalling, 2016, 28: 1894–1903; doi.org/10.1016/j.cellsig.2016.09.004 | ||
Me14346ADH |
Human melanoma cell line | Human | skin | cell line | adherent | siRNA | RNA-Interference | Metafectene | publication | A.Tuccitto et al., STEM CELLS, 2016, 34:2449-2460; doi.org/10.1002/stem.2413 | Link | ||
Me15888S |
Human melanoma cell line | Human | skin | cell line | adherent | siRNA | RNA-Interference | Metafectene | publication | A.Tuccitto et al., STEM CELLS, 2016, 34:2449-2460; doi.org/10.1002/stem.2413 | Link | ||
MEC-2 |
Human chronic B cell leukemia cell line | DSMZ ACC500 | Human | immune system | cell line | suspension | siRNA | RNA-Interference | Metafectene PRO | publication | S. W. Hofbauer et al., Cancer Res., Sep 2010; 70: 7336 - 7344 | Link | |
MG-63 |
Human bone osteosarcome cell line | ATCC CRL-1427 | Human | bone | cell line | adherent | siRNA | RNA-Interference | Metafectene PRO | publication | A. Notaro et al., Int. J. of Oncology, 2016, 48: 1039-1044; DOI: 10.3892/ijo.2015.3307 | Link | |
MG-63 |
Human bone osteosarcome cell line | ATCC CRL-1427 | Human | bone | cell line | adherent | siRNA | RNA-Interference | Metafectene PRO | publication | A. D'Anneo et al., J. Cell. Physiol., 2013, 228: 952–967, DOI: 10.1002/jcp.24131 | ||
MG-63 |
Human bone osteosarcome cell line | ATCC CRL-1427 | Human | bone | cell line | adherent | siRNA | RNA-Interference | Metafectene SI | publication | V. R. Lo Vasco et al., SpringerPlus, 2016, 5:156; DOI 10.1186/s40064-016-1768-6 | Link | |
MG-63 |
Human bone osteosarcome cell line | ATCC CRL-1427 | Human | bone | cell line | adherent | siRNA | RNA-Interference | Metafectene PRO | publication | C. Kerzendorfer et al., Hum. Mol. Genet., Apr 2010; 19: 1324 - 1334 | Link | |
MG-63 |
Human bone osteosarcome cell line | ATCC CRL-1427 | Human | bone | cell line | adherent | siRNA | RNA-Interference | Metafectene PRO | publication | A. Notaro et al., Int. J. Biol. Sci., 2014, 10(5): 466-478, doi: 10.7150/ijbs.8337 | Link | |
MG-63 |
Human bone osteosarcome cell line | ATCC CRL-1427 | Human | bone | cell line | adherent | siRNA | RNA-Interference | Metafectene PRO | publication | D. Alcantara, PhD Thesis, 2012, University of Sussex | Link | |
MIA PaCa-2 |
Human pancreas carcinoma cell line | ATCC CRL-1420 | Human | digestive organs | cell line | adherent | siRNA | RNA-Interference | Metafectene PRO | publication | L. Qin et al., Oncotarget, 2016, 7 (14): 17726-17736 | Link | |
MIA PaCa-2 |
Human pancreas carcinoma cell line | ATCC CRL-1420 | Human | digestive organs | cell line | adherent | siRNA | RNA-Interference | Metafectene PRO | publication | L. Qin et al., Mol. Pharmacol., Oct 2014; 86: 561 - 569 | ||
MIA PaCa-2 |
Human pancreas carcinoma cell line | ATCC CRL-1420 | Human | digestive organs | cell line | adherent | siRNA | RNA-Interference | Metafectene PRO | publication | L. Qin, PhD Thesis, 2014, Indiana University | ||
MIA PaCa-2 |
Human pancreas carcinoma cell line | ATCC CRL-1420 | Human | digestive organs | cell line | adherent | siRNA | RNA-Interference | Metafectene | publication | P. J. Hodul et al., PLoS ONE, 2013, 8(2): e52526. doi:10.1371/journal.pone.0052526 | Link |